Eric Claassen

9.0k total citations · 1 hit paper
198 papers, 6.9k citations indexed

About

Eric Claassen is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric Claassen has authored 198 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 55 papers in Molecular Biology and 38 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric Claassen's work include Monoclonal and Polyclonal Antibodies Research (36 papers), Immunotherapy and Immune Responses (27 papers) and Probiotics and Fermented Foods (23 papers). Eric Claassen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (36 papers), Immunotherapy and Immune Responses (27 papers) and Probiotics and Fermented Foods (23 papers). Eric Claassen collaborates with scholars based in Netherlands, United States and Belgium. Eric Claassen's co-authors include Nico van Rooijen, Jon D. Laman, W.J.A. Boersma, M. van den Nieuwboer, Randolph J. Noelle, Jan Trapman, Albert O. Brinkmann, C.B.M. Maassen, N. Kors and Cor Berrevoets and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Eric Claassen

198 papers receiving 6.5k citations

Hit Papers

A mutation in the ligand ... 1990 2026 2002 2014 1990 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eric Claassen 2.3k 2.0k 906 887 885 198 6.9k
Wolfgang König 3.9k 1.7× 2.6k 1.3× 941 1.0× 1.3k 1.4× 279 0.3× 433 11.4k
Hong Zhang 3.1k 1.3× 1.9k 0.9× 726 0.8× 210 0.2× 473 0.5× 361 8.9k
John R. Murphy 1.9k 0.8× 2.4k 1.2× 370 0.4× 684 0.8× 178 0.2× 178 6.1k
Timothy P. Hughes 2.9k 1.3× 1.6k 0.8× 965 1.1× 685 0.8× 723 0.8× 503 25.0k
Michiko Kobayashi 3.2k 1.4× 5.4k 2.7× 476 0.5× 641 0.7× 232 0.3× 155 11.1k
Ian R. Sanderson 1.7k 0.8× 1.2k 0.6× 647 0.7× 620 0.7× 452 0.5× 184 8.4k
Thomas N. Williams 1.1k 0.5× 1.3k 0.7× 298 0.3× 1.2k 1.4× 241 0.3× 217 14.4k
Terry Smith 2.5k 1.1× 807 0.4× 398 0.4× 550 0.6× 316 0.4× 241 8.0k
Wei Li 2.8k 1.2× 1.9k 0.9× 1.0k 1.1× 894 1.0× 97 0.1× 652 10.6k
Jian Li 3.3k 1.4× 1.7k 0.8× 731 0.8× 1.3k 1.5× 174 0.2× 409 9.1k

Countries citing papers authored by Eric Claassen

Since Specialization
Citations

This map shows the geographic impact of Eric Claassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Claassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Claassen more than expected).

Fields of papers citing papers by Eric Claassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Claassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Claassen. The network helps show where Eric Claassen may publish in the future.

Co-authorship network of co-authors of Eric Claassen

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Claassen. A scholar is included among the top collaborators of Eric Claassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Claassen. Eric Claassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Claassen, Eric, et al.. (2024). The pharmaceutical productivity gap – Incremental decline in R&D efficiency despite transient improvements. Drug Discovery Today. 29(11). 104160–104160. 5 indexed citations
2.
Tonda, Alberto, Patrick Tabeling, Jessica Vanhomwegen, et al.. (2023). An Innovative AI-based primer design tool for precise and accurate detection of SARS-CoV-2 variants of concern. Scientific Reports. 13(1). 15782–15782. 2 indexed citations
3.
Claassen, Eric, et al.. (2021). Lower Respiratory Tract Infection Trends in East and South-East Asia: In the Light of Economic and Health Care Development. Global Pediatric Health. 8. 2333794X21989530–2333794X21989530. 7 indexed citations
4.
5.
Nieuwboer, M. van den, Saskia van Hemert, Eric Claassen, & Willem M. de Vos. (2016). Lactobacillus plantarum WCFS 1 and its host interaction: a dozen years after the genome. Microbial Biotechnology. 9(4). 452–465. 103 indexed citations
6.
Burgwal, Linda van de, Leslie A. Reperant, Albert D. M. E. Osterhaus, et al.. (2016). Self-Centric and Altruistic Unmet Needs for Ebola: Barriers to International Preparedness. Disaster Medicine and Public Health Preparedness. 10(4). 644–648. 9 indexed citations
7.
Claassen, Eric, et al.. (2014). Adopting health apps, what's hindering doctors and patients?. PLoS ONE. 6(16). 2204–2217. 1 indexed citations
8.
Nieuwboer, M. van den, Eric Claassen, Lorenzo Morelli, Francisco Guarner, & Robert J. Brummer. (2014). Probiotic and synbiotic safety in infants under two years of age. Beneficial Microbes. 5(1). 45–60. 57 indexed citations
9.
Pronker, E.S., et al.. (2013). Risk in Vaccine Research and Development Quantified. PLoS ONE. 8(3). e57755–e57755. 169 indexed citations
10.
Hell, Markus, et al.. (2013). Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Beneficial Microbes. 4(1). 39–51. 47 indexed citations
11.
Maassen, C.B.M., W.J.A. Boersma, Conny van Holten-Neelen, Eric Claassen, & Jon D. Laman. (2003). Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Vaccine. 21(21-22). 2751–2757. 78 indexed citations
12.
Boersma, W.J.A., et al.. (1995). Migration of human antigen-presenting cells in a human skin graft onto nude mice model after contact sensitization.. PubMed Central. 86(2). 296–303. 8 indexed citations
13.
Abacıoğlu, Hakan, Timothy Fouts, Jon D. Laman, et al.. (1994). Epitope Mapping and Topology of Baculovirus-Expressed HIV-1 gp160 Determined with a Panel of Murine Monoclonal Antibodies. AIDS Research and Human Retroviruses. 10(4). 371–381. 164 indexed citations
14.
Laman, Jon D., Marc M. Schellekens, George K. Lewis, et al.. (1993). A Hidden Region in the Third Variable Domain of HIV-1 IIIB gp120 Identified by a Monoclonal Antibody. AIDS Research and Human Retroviruses. 9(7). 605–612. 18 indexed citations
15.
Eertwegh, Alfons J. van den, Randolph J. Noelle, Michael Roy, et al.. (1993). In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.. The Journal of Experimental Medicine. 178(5). 1555–1565. 218 indexed citations
16.
Eertwegh, Alfons J.M. van den, Jon D. Laman, Marc M. Schellekens, W.J.A. Boersma, & Eric Claassen. (1992). Complement‐mediated follicular localization of T‐independent type‐2 antigens: the role of marginal zone macrophages revisited. European Journal of Immunology. 22(3). 719–726. 52 indexed citations
17.
Laman, Jon D., et al.. (1992). Production of monomeric antigen-enzyme conjugate to study requirements for follicular immune complex trapping. Histochemistry and Cell Biology. 97(2). 189–194. 2 indexed citations
18.
Gerritse, Koen, et al.. (1991). Conjugate formation in urea: coupling of insoluble peptides to alkaline phosphatase for ELISA and in situ detection of antibody-forming cells.. Journal of Histochemistry & Cytochemistry. 39(7). 987–992. 4 indexed citations
19.
Zegers, Netty D., Koen Gerritse, C. Deen, W.J.A. Boersma, & Eric Claassen. (1990). An improved conjugation method for controlled covalent coupling of synthetic peptides to proteins using glutaraldehyde in a dialysis method. Journal of Immunological Methods. 130(2). 195–200. 45 indexed citations
20.
Claassen, Eric, et al.. (1988). Sequential double immunocytochemical staining for in situ identification of an auto-anti-allotype immune response in allotype-suppressed rabbits.. Journal of Histochemistry & Cytochemistry. 36(12). 1455–1461. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026